Dr. Teresa Spehar joined Synthetic Genomics in November, 2008 and manages all aspects of SGI’s intellectual property. In addition to overseeing SGI’s patent portfolio and counseling management regarding IP issues, she acts as liaison to the J. Craig Venter Institute to protect synthetic biology advances in collaborations between the organizations. Dr. Spehar has spent the last 15 years working as a patent attorney in both biotechnology companies and a national law firm in San Diego, CA. Prior to entering law school to focus on intellectual property, Dr. Spehar worked as a guest researcher at the Centers for Disease Control in Atlanta, GA.
She is a graduate of the Johns Hopkins University School of Medicine (Ph.D., Pharmacology and Molecular Sciences) and of California Western School of Law. She is admitted to practice in California and before the U.S. Patent and Trademark Office.